Kringle Pharma Inc (4884 JP): 1H FY09/26 Flash update
Revenue and gross profit for 1H FY09/26 were JPY37mn, both increasing by 2.2% year-on-year. Operating loss for 1H FY09/26 was JPY515mn, slightly...
93 Views
Kringle Pharma Inc (4884 JP): Q1 FY09/26 flash update
FY09/26 results show revenue and gross profit at JPY19mn (+2.3% YoY), with an operating loss of JPY200mn. Current assets decreased by JPY90mn to...
192 Views
Kringle Pharma Inc (4884 JP): Full-year FY09/25 flash update
FY09/25 revenue was JPY72mn, with a net loss of JPY916mn, primarily from technology access fees from Claris Biotherapeutics. FY09/26 forecasts...
123 Views
Kringle Pharma Inc (4884 JP): Q3 FY09/25 flash update
Revenue and gross profit for cumulative Q3 FY09/25 were JPY54mn, down 12.4% YoY, with SG&A expenses up 23.6%. Operating, recurring, and net...
359 Views
Kringle Pharma Inc (4884 JP): 1H FY09/25 flash update
Revenue and gross profit for 1H FY09/25 were JPY36mn, down 16.5% YoY, with SG&A expenses up 33.7%. Current assets decreased by JPY491mn,...
286 Views